about
An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesThe Incremental Induction of Neuroprotective Properties by Multiple Therapeutic Strategies for Primary and Secondary Neural InjuryRole of pro-inflammatory cytokines released from microglia in Alzheimer's diseaseHeart failure and Alzheimer's diseaseStem cell treatment for Alzheimer's diseaseInsulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndromeThe flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model miceAutologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in β amyloid-induced neurodegenerationOcular indicators of Alzheimer's: exploring disease in the retinaAPOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspectiveGDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body DementiaSelective Brain-Targeted Antagonism of p38 MAPKα Reduces Hippocampal IL-1β Levels and Improves Morris Water Maze Performance in Aged RatsPhysical activity, inflammation, and volume of the aging brainA role for human brain pericytes in neuroinflammation.Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.Inflammasomes in neuroinflammation and changes in brain function: a focused review.Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasisThe effect of treadmill exercise on inflammatory responses in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.Eryptosis as a marker of Parkinson's diseaseProtection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients.Peripherally triggered and GSK-3β-driven brain inflammation differentially skew adult hippocampal neurogenesis, behavioral pattern separation and microglial activation in response to ibuprofen.α7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid β42 accumulation in the mouse brain to impair memory.The relationship of serum macrophage inhibitory cytokine-1 levels with gray matter volumes in community-dwelling older individuals.Evaluation of inflammation-related genes polymorphisms in Mexican with Alzheimer's disease: a pilot study.The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementiaDeficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.The Ever-Changing Morphology of Hippocampal Granule Neurons in Physiology and PathologyViscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)The neuropathology and cerebrovascular mechanisms of dementiaBrain intracellular metabolites are freely diffusing along cell fibers in grey and white matter, as measured by diffusion-weighted MR spectroscopy in the human brain at 7 T.Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's DiseaseArabidopsis thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer's disease in vitroSerum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.Early onset Alzheimer's disease and oxidative stress.Toll-like receptors 2, -3 and -4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1β release.Targeting Hsp90 and its co-chaperones to treat Alzheimer's diseaseBeyond the borders: the gates and fences of neuroimmune interaction.
P2860
Q26751302-A5A559EE-5603-4697-8E6D-9E26F7343A3DQ26771812-5E618C59-424B-4BBA-80D0-939DC97E6C36Q26795755-C9865852-AFBD-4237-88EF-9435CD70BB14Q26799870-71FDB18E-FCDF-40D6-AD60-19CE2879262CQ26852526-A2F1392D-9F43-49CB-8BF8-17A5529425EDQ27007013-A3B02527-DEE0-4BA0-9388-2FA9041D75C0Q27008997-54B9E102-C77E-43AD-B39B-633A1D459093Q27305145-57756207-42B9-4C90-884A-C018453757BFQ27334336-80DE1701-A6D2-41EC-8B8F-302B766F4A90Q28078670-FD67553D-C0BE-46E7-9535-BDC2FDD239FBQ28085213-229AD3C9-F54C-4B83-A450-9310EEA167C1Q28550541-78796A22-3854-4E2E-82AD-6BCE12FE6823Q28828716-5A0B42C4-6A17-42B4-BA90-C7D0C1F07D3DQ33827770-964A5D78-83B0-49BA-AEA8-0A4E34F325B6Q33926836-20BF5F2D-FE5B-4AFD-8F1A-63A3F13E2CF7Q34064026-7DC63EE3-D60E-4112-8362-5E5F5D54311AQ34299338-7CA2D256-E2FB-41D0-9822-83A17E99CCF4Q34471200-495B85EA-B7DF-462B-913E-8FDCC427B4B1Q34563406-A85FC9D3-60C3-46BF-A1B1-0508CE29CB42Q34585744-6D844DB3-1F4F-49B2-9A87-22443E34958BQ35058396-5F462B65-D940-4000-AE48-3105DBFC9C58Q35106556-156ED6DE-DEE0-4D04-93AD-53852258FFDFQ35150206-81DBBF6C-96A6-401B-AEAE-2387F3A00456Q35225004-5B76C3A5-D728-4E8D-A844-AC8D66410F18Q35388790-9CA810D6-7F51-4DB6-843D-9EB1A4B8B0B1Q35617592-1217C4FB-2B23-4F0F-8C3A-DDF4042BEDB8Q35706990-D42E2FE4-D432-41C7-8B10-0A4E5106CBD6Q36072048-2C8FC69B-272A-4A4F-A726-7BB9E52CE2F0Q36083357-76824B57-17F0-4740-8C7D-760F8F52E6FAQ36475393-DB866818-FC58-4BF1-8A7F-D84C048A48C4Q36546334-D02717B9-F890-46E6-8890-0133A289B1E2Q36593201-D7422F3B-6216-4150-AE88-7837E149D6AAQ36931588-F2E1B5FF-02F7-4264-A9E3-C1BF935E4CB5Q36939748-24DE6F20-1DED-4472-AA60-1D0698070D9AQ37073034-8E72D5E1-1074-44F7-98D4-7B81BFDE76A2Q37342809-E5B7C662-F5E8-48BD-A022-925CD5E2E6C8Q37616574-34F4BF22-0BFC-4327-85A6-0C1564BB8894Q37738372-45CEA626-BCFA-4E61-B39B-426C64FB69B1Q38234720-ABFF2BB0-F11D-4210-B8CC-79D7CB2072D0Q38262936-E9FA776D-F52C-4274-BC13-F88B4664E8FB
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inflammatory process in Alzheimer's Disease
@ast
Inflammatory process in Alzheimer's Disease
@en
Inflammatory process in Alzheimer's Disease
@nl
type
label
Inflammatory process in Alzheimer's Disease
@ast
Inflammatory process in Alzheimer's Disease
@en
Inflammatory process in Alzheimer's Disease
@nl
prefLabel
Inflammatory process in Alzheimer's Disease
@ast
Inflammatory process in Alzheimer's Disease
@en
Inflammatory process in Alzheimer's Disease
@nl
P2093
P2860
P3181
P356
P1476
Inflammatory process in Alzheimer's Disease
@en
P2093
Danira Toral-Rios
Diana Franco-Bocanegra
Juana Villeda-Hernández
Marco A Meraz-Ríos
Victoria Campos-Peña
P2860
P3181
P356
10.3389/FNINT.2013.00059
P577
2013-01-01T00:00:00Z